Infliximab 产品
(Infliximab)
Categories
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended Infliximab 抗体
Recommended Infliximab ELISA试剂盒
- (1)
Latest Publications for our Infliximab Products
: "Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study." in: Journal of Crohn's & colitis, Vol. 12, Issue 3, pp. 289-297, (2018) (PubMed).: "Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated ..." in: Journal of Crohn's & colitis, Vol. 12, Issue 6, pp. 644-652, (2018) (PubMed).
: "A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring." in: OncoTargets and therapy, Vol. 11, pp. 113-121, (2018) (PubMed).
: "Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors." in: Digestive diseases (Basel, Switzerland), Vol. 36, Issue 1, pp. 40-48, (2018) (PubMed).
: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." in: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).
: "Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis." in: Die Pharmazie, Vol. 72, Issue 2, pp. 95-97, (2018) (PubMed).
: "Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease." in: Gut and liver, Vol. 11, Issue 1, pp. 55-61, (2017) (PubMed).
: "Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. ..." in: Expert opinion on drug safety, Vol. 16, Issue 8, pp. 885-890, (2017) (PubMed).
: "Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre." in: Digestive diseases (Basel, Switzerland), Vol. 35, Issue 1-2, pp. 91-100, (2017) (PubMed).
: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).
您还需要查找其他产品吗?
- INF2
- INE1
- Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1
- Indoleacetic Acid
- Indole 3 Acetic Acid
- Indian Hedgehog
- INCE
- INCC
- INCA1
- Inactivation No Afterpotential D
- INA
- IN80D
- Imprintor 1
- Importin 9
- Importin 8
- Importin 5
- Importin 4
- Importin 11
- IMPG2
- IMPG1
- Influenza A H1N1 PB1
- Influenza A Matrix Protein 2
- Influenza A NS1
- Influenza A Virus H3N2
- Influenza A Virus H5N1
- Influenza A Virus Matrix Protein 1
- Influenza A Virus Neuraminidase
- Influenza A Virus NS2
- Influenza B Virus Neuraminidase
- Influenza Hemagglutinin HA1 Chain
- Influenza Hemagglutinin HA2 Chain
- Influenza Nucleoprotein
- Influenza Polymerase Acidic
- Influenza Polymerase Basic 2
- ING1
- ING2
- ING3
- ING4
- ING5
- INHA